Literature DB >> 16974125

[New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].

Jürgen Brockmöller1, Klaus Junker, Gabriele Multhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16974125     DOI： 10.1159/000094952

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


× No keyword cloud information.
  2 in total

1.  Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.

Authors:  En-hai Cui; Hong-jiao Li; Feng Hua; Bin Wang; Wei Mao; Xue-ren Feng; Jian-you Li; Xiang Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

2.  RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.

Authors:  Xiang Wang; Enhai Cui; Huazong Zeng; Feng Hua; Bin Wang; Wei Mao; Xueren Feng
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.